Skip to content

study of heart injury by laboratory investigation in corona positive patients.

Co-relation of biochemical cardiac markers of cardiac injury with clinical outcome of COVID 19 patients with or without preexisting cardiac illness.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029068
Enrollment
200
Registered
2020-11-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Vijaysinh Parmar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted in SVP Hospital Positive realâ??time polymerase chain reaction (RTâ??PCR) assay from nasoâ??pharyngeal and oral swab specimens Patients having complete clinical data

Exclusion criteria

Exclusion criteria: Incomplete clinical data Clotted samples Lipemic samples

Design outcomes

Primary

MeasureTime frame
To check myocardial injury by analysis of cardiac biomarker level in covid 19 patientsTimepoint: At baseline and 8 weeks

Secondary

MeasureTime frame
To know the progression and outcome of covid 19 patientsTimepoint: 8 weeks;To compare severity of myocardial injury in pre-existent cardiovascular disease patients with other patientsTimepoint: 8 weeks

Countries

India

Contacts

Public ContactDr Vijaysinh Parmar

smt NHL Municipal Medical College

drvijaysinhparmar@gmail.com9909429619

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026